Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan - Galiè, N D; Ghofrani, H A; Jansa, P (Eur Heart J, 2014)
et al.